{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T21:07:20Z","timestamp":1794863240220,"version":"4.9.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T00:00:00Z","timestamp":1662076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T00:00:00Z","timestamp":1662076800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Supported by ERDF (FEDER) Operational Programme of Aragon Health Research Institute","award":["No.  B26_17D."],"award-info":[{"award-number":["No.  B26_17D."]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>In recent years, some studies have generated controversy since they conclude that intraoperatively pharmacological reversal of neuromuscular blockade does not contribute to the reduction of postoperative residual neuromuscular blockade or pulmonary complications. Therefore, the main objective of this study was to assess the incidence of residual neuromuscular blockade and postoperative pulmonary complications according to spontaneous or pharmacological neuromuscular reversal. The secondary aim was to present a prognostic model to predict the probability of having postoperative residual neuromuscular blockade depending on a patient's comorbidities and intraoperative neuromuscular blocking agents management. A single-center, prospective, observational cohort study including patients undergoing surgical procedures with general anesthesia was designed. A total of 714 patients were analyzed. Patients were divided into four groups: cisatracurium with spontaneous reversal, cisatracurium with neostigmine antagonism, rocuronium with spontaneous reversal, and rocuronium with sugammadex antagonism. According to our binomial generalized linear model, none of the studied comorbidities was a predisposing factor for an increase in the residual neuromuscular blockade. However, in our study, pharmacological reversal of rocuronium with sugammadex and, particularly, neuromuscular monitoring during surgery were the factors that most effectively reduced the risk of residual neuromuscular blockade as well as early and late postoperative pulmonary complications.<\/jats:p>","DOI":"10.1038\/s41598-022-18917-y","type":"journal-article","created":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T06:05:52Z","timestamp":1662098752000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Predictive study of pharmacological reversal for residual neuromuscular blockade and postoperative pulmonary complications: a prospective, observational, cohort study"],"prefix":"10.1038","volume":"12","author":[{"given":"Cristian","family":"Arag\u00f3n-Bened\u00ed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Pascual-Bellosta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Ortega-Lucea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Visiedo-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Mart\u00ednez-Ubieto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Research Group in Anaesthesia, Resuscitation, and Perioperative Medicine of Institute for Health Research Arag\u00f3n (ISS Arag\u00f3n)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristian","family":"Arag\u00f3n-Bened\u00ed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Pascual-Bellosta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Ortega-Lucea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Mart\u00ednez-Ubieto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Alfonso","family":"Mu\u00f1oz-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo","family":"P\u00e9rez-Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natividad","family":"Quesada-Gimeno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc\u00eda","family":"Tard\u00f3s-Ascaso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Visiedo-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Jim\u00e9nez-Bernad\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berta","family":"P\u00e9rez-Otal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Romero-Caro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,2]]},"reference":[{"key":"18917_CR1","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s00464-014-3711-7","volume":"29","author":"M Blobner","year":"2015","unstructured":"Blobner, M. et al. Neuromuscular blockade improves surgical conditions (NISCO). Surg. Endosc. 29, 627\u2013636 (2015).","journal-title":"Surg. Endosc."},{"key":"18917_CR2","doi-asserted-by":"publisher","first-page":"e6329","DOI":"10.1136\/bmj.e6329","volume":"345","author":"M Grosse-Sundrup","year":"2012","unstructured":"Grosse-Sundrup, M. et al. Intermediate acting non-depolarizing neuromuscular blocking agents and risk of postoperative respiratory complications: Prospective propensity score matched cohort study. BMJ 345, e6329 (2012).","journal-title":"BMJ"},{"key":"18917_CR3","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1097\/ALN.0000000000003256","volume":"132","author":"S Kheterpal","year":"2020","unstructured":"Kheterpal, S. et al. Sugammadex versus neostigmine for reversal of neuromuscular blockade and postoperative pulmonary complications (STRONGER): A multi-center matched cohort analysis. Anesthesiology 132, 1371\u20131381 (2020).","journal-title":"Anesthesiology"},{"key":"18917_CR4","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.jclinane.2019.02.014","volume":"57","author":"NY Kim","year":"2019","unstructured":"Kim, N. Y. et al. Influence of reversal of neuromuscular blockade with sugammadex or neostigmine on postoperative quality of recovery following a single bolus dose of rocuronium: A prospective, randomized, double-blinded, controlled study. J. Clin. Anesth. 57, 97\u2013102 (2019).","journal-title":"J. Clin. Anesth."},{"key":"18917_CR5","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.bja.2020.01.016","volume":"124","author":"BM Togioka","year":"2020","unstructured":"Togioka, B. M. et al. Randomised controlled trial of sugammadex or neostigmine for reversal of neuromuscular block on the incidence of pulmonary complications in older adults undergoing prolonged surgery. Br. J. Anaesth. 124, 553\u2013561 (2020).","journal-title":"Br. J. Anaesth."},{"key":"18917_CR6","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1097\/ALN.0000000000001279","volume":"125","author":"CM Bulka","year":"2016","unstructured":"Bulka, C. M. et al. Nondepolarizing neuromuscular blocking agents, reversal, and risk of postoperative pneumonia. Anesthesiology 125, 647\u2013655 (2016).","journal-title":"Anesthesiology"},{"key":"18917_CR7","first-page":"735","volume":"82","author":"J Martinez-Ubieto","year":"2016","unstructured":"Martinez-Ubieto, J. et al. Prospective study of residual neuromuscular block and postoperative respiratory complications in patients reversed with neostigmine versus sugammadex. Minerva Anestesiol. 82, 735\u2013742 (2016).","journal-title":"Minerva Anestesiol."},{"key":"18917_CR8","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1213\/ANE.0000000000002670","volume":"127","author":"M Naguib","year":"2018","unstructured":"Naguib, M. et al. Consensus statement on perioperative use of neuromuscular monitoring. Anesth. Analg. 127, 71\u201380 (2018).","journal-title":"Anesth. Analg."},{"issue":"1","key":"18917_CR9","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.accpm.2020.01.005","volume":"39","author":"B Plaud","year":"2020","unstructured":"Plaud, B. et al. Guidelines on muscle relaxants and reversal in anaesthesia. Anaesth. Crit. Care Pain Med. 39(1), 125\u2013142 (2020).","journal-title":"Anaesth. Crit. Care Pain Med."},{"key":"18917_CR10","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/anae.13316","volume":"71","author":"MR Checketts","year":"2016","unstructured":"Checketts, M. R. et al. Recommendations for standards of monitoring during anaesthesia and recovery 2015: Association of Anaesthetists of Great Britain and Ireland. Anaesthesia 71, 85\u201393 (2016).","journal-title":"Anaesthesia"},{"key":"18917_CR11","first-page":"45","volume":"30","author":"RK Stoelting","year":"2016","unstructured":"Stoelting, R. K. Monitoring of neuromuscular blockade: What would you expect if you were the patient?. APSF Newslett. 30, 45\u201347 (2016).","journal-title":"APSF Newslett."},{"key":"18917_CR12","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1097\/ALN.0000000000001795","volume":"127","author":"EC Hyman","year":"2017","unstructured":"Hyman, E. C. & Brull, S. J. Clarification: Current status of neuromuscular reversal and monitoring, challenges and opportunities. Anesthesiology 127, 730 (2017).","journal-title":"Anesthesiology"},{"key":"18917_CR13","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1213\/ANE.0000000000000261","volume":"119","author":"MM Todd","year":"2014","unstructured":"Todd, M. M., Hindman, B. J. & King, B. J. The implementation of quantitative electromyographic neuromuscular monitoring in an academic anesthesia department. Anesth. Analg. 119, 323\u2013331 (2014).","journal-title":"Anesth. Analg."},{"key":"18917_CR14","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S2213-2600(18)30294-7","volume":"7","author":"E Kirmeier","year":"2019","unstructured":"Kirmeier, E. et al. Post-anaesthesia pulmonary complications after use of muscle relaxants (POPULAR): A multicentre, prospective observational study. Lancet Respir. Med. 7, 129\u2013140 (2019).","journal-title":"Lancet Respir. Med."},{"key":"18917_CR15","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1097\/ALN.0000000000000334","volume":"121","author":"V Mazo","year":"2014","unstructured":"Mazo, V. et al. Prospective external validation of a predictive score for postoperative pulmonary complications. Anesthesiology 121, 219\u2013231 (2014).","journal-title":"Anesthesiology"},{"issue":"6","key":"18917_CR16","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1097\/EJA.0b013e328344be2d","volume":"28","author":"J Canet","year":"2011","unstructured":"Canet, J. et al. PERISCOPE study: Predicting post-operative pulmonary complications in Europe. Eur. J. Anaesthesiol. 28(6), 459\u2013461 (2011).","journal-title":"Eur. J. Anaesthesiol."},{"issue":"2","key":"18917_CR17","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1213\/ANE.0b013e3182999672","volume":"117","author":"Y Kotake","year":"2013","unstructured":"Kotake, Y. et al. Reversal with sugammadex in the absence of monitoring did not preclude residual neuromuscular block. Anesthesia Analg. 117(2), 345\u2013351 (2013).","journal-title":"Anesthesia Analg."},{"key":"18917_CR18","first-page":"1","volume":"27","author":"G Cammu","year":"2020","unstructured":"Cammu, G. Residual neuromuscular blockade and postoperative pulmonary complications: What does the recent evidence demonstrate?. Curr. Anesthesiol. Rep. 27, 1\u20136 (2020).","journal-title":"Curr. Anesthesiol. Rep."},{"key":"18917_CR19","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1111\/anae.14160","volume":"73","author":"AM Hristovska","year":"2018","unstructured":"Hristovska, A. M., Duch, P., Allingstrup, M. & Afshari, A. The comparative efficacy and safety of sugammadex and neostigmine in reversing neuromuscular blockade in adults. A cochrane systematic review with meta-analysis and trial sequential analysis. Anaesthesia 73, 631\u2013641 (2018).","journal-title":"Anaesthesia"},{"key":"18917_CR20","first-page":"1267","volume":"82","author":"CL Errando","year":"2016","unstructured":"Errando, C. L., Garutti, I., Mazzinari, G., D\u00edaz-Cambronero, \u00d3. & Bebawy, J. F. Residual neuromuscular blockade in the postanesthesia care unit: Observational cross-sectional study of a multicenter cohort. Minerva Anestesiol. 82, 1267\u20131277 (2016).","journal-title":"Minerva Anestesiol."},{"key":"18917_CR21","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1093\/bja\/aev104","volume":"115","author":"B Brueckmann","year":"2015","unstructured":"Brueckmann, B. et al. Effects of sugammadex on incidence of postoperative residual neuromuscular blockade: A randomized, controlled study. Br. J. Anaesth. 115, 743\u2013751 (2015).","journal-title":"Br. J. Anaesth."},{"key":"18917_CR22","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1097\/ACO.0000000000000395","volume":"29","author":"T Fuchs-Buder","year":"2016","unstructured":"Fuchs-Buder, T., Nemes, R. & Schmartz, D. Residual neuromuscular blockade: Management and impact on postoperative pulmonary outcome. Curr. Opin. Anaesthesiol. 29, 662\u2013667 (2016).","journal-title":"Curr. Opin. Anaesthesiol."},{"key":"18917_CR23","unstructured":"Merck & Co. Bridion\u00ae (sugammadex) injection, for intravenous use: US prescribing information (2015) https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2015\/022225lbl.pdf (Accessed 14 Apr 2022)."},{"key":"18917_CR24","unstructured":"European Medicines Agency. Bridion\u00ae (sugammadex) 100 mg\/ml solution for injection: EU summary of product characteristics (2015) https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/bridion (Accessed 14 Apr 2022)."},{"key":"18917_CR25","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s12871-018-0605-6","volume":"18","author":"HD De Boer","year":"2018","unstructured":"De Boer, H. D., Carlos, R. V. & Brull, S. J. Is lower-dose sugammadex a cost-saving strategy for reversal of deep neuromuscular block? Facts and fiction. BMC Anesthesiol. 18, 159 (2018).","journal-title":"BMC Anesthesiol."},{"issue":"10","key":"18917_CR26","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1007\/s40265-016-0604-1","volume":"76","author":"GM Keating","year":"2016","unstructured":"Keating, G. M. Sugammadex: A review of neuromuscular blockade reversal. Drugs 76(10), 1041\u20131052 (2016).","journal-title":"Drugs"},{"key":"18917_CR27","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1007\/s12630-019-01419-3","volume":"66","author":"E Alday","year":"2019","unstructured":"Alday, E. et al. Effects of neuromuscular block reversal with sugammadex versus neostigmine on postoperative respiratory outcomes after major abdominal surgery: A randomized-controlled trial. Canad. J. Anesth. 66, 1328\u20131337 (2019).","journal-title":"Canad. J. Anesth."},{"key":"18917_CR28","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/anae.13738","volume":"72","author":"M Naguib","year":"2017","unstructured":"Naguib, M., Brull, S. J. & Johnson, K. B. Conceptual and technical insights into the basis of neuromuscular monitoring. Anaesthesia 72, 16\u201337 (2017).","journal-title":"Anaesthesia"},{"key":"18917_CR29","doi-asserted-by":"publisher","first-page":"46","DOI":"10.4103\/0019-5049.108562","volume":"57","author":"T Ledowsky","year":"2013","unstructured":"Ledowsky, T. et al. Introduction of sugammadex as reversal agent: Impact on the incidence of residual neuromuscular blockade and postoperative patient outcome. Indian J. Anaesth. 57, 46\u201351 (2013).","journal-title":"Indian J. Anaesth."},{"issue":"2","key":"18917_CR30","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.bja.2021.04.026","volume":"127","author":"T Ledowski","year":"2021","unstructured":"Ledowski, T. et al. Reversal of residual neuromuscular block with neostigmine or sugammadex and postoperative pulmonary complications: A prospective, randomised, double-blind trial in high-risk older patients. Br. J. Anaesth. 127(2), 316\u2013323 (2021).","journal-title":"Br. J. Anaesth."},{"key":"18917_CR31","doi-asserted-by":"publisher","first-page":"75","DOI":"10.5152\/TJAR.2018.200318","volume":"46","author":"C Unterbuchner","year":"2018","unstructured":"Unterbuchner, C. Neuromuscular block and blocking agents in 2018. Turk. J. Anaesthesiol. Reanim. 46, 75\u201380 (2018).","journal-title":"Turk. J. Anaesthesiol. Reanim."},{"key":"18917_CR32","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1097\/EJA.0000000000000585","volume":"34","author":"R Nemes","year":"2017","unstructured":"Nemes, R. et al. Impact of reversal strategies on the incidence of postoperative residual paralysis after rocuronium relaxation without neuromuscular monitoring: A partially randomised placebo controlled trial. Eur. J. Anaesthesiol. 34, 609\u2013616 (2017).","journal-title":"Eur. J. Anaesthesiol."},{"issue":"6","key":"18917_CR33","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1097\/ALN.0000000000003735","volume":"134","author":"G Li","year":"2021","unstructured":"Li, G. et al. Postoperative pulmonary complications\u2019 association with sugammadex versus neostigmine: A retrospective registry analysis. Anesthesiology 134(6), 862\u2013873 (2021).","journal-title":"Anesthesiology"},{"key":"18917_CR34","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1097\/ALN.0000000000000674","volume":"122","author":"DJ McLean","year":"2015","unstructured":"McLean, D. J. et al. Dose-dependent association between intermediate-acting neuromuscular-blocking agents and postoperative respiratory complications. Anesthesiology 122, 1201\u20131213 (2015).","journal-title":"Anesthesiology"},{"key":"18917_CR35","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1097\/ALN.0000000000000440","volume":"121","author":"N Sasaki","year":"2014","unstructured":"Sasaki, N. et al. Effects of neostigmine reversal of nondepolarizing neuromuscular blocking agents on postoperative respiratory outcomes: A prospective study. Anesthesiology 121, 959\u2013968 (2014).","journal-title":"Anesthesiology"},{"key":"18917_CR36","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1111\/anae.13277","volume":"70","author":"A Abad-Gurumeta","year":"2015","unstructured":"Abad-Gurumeta, A. et al. A systematic review of sugammadex vs neostigmine for reversal of neuromuscular blockade. Anaesthesia 70, 1441\u20131452 (2015).","journal-title":"Anaesthesia"},{"issue":"3","key":"18917_CR37","first-page":"415","volume":"44","author":"Y Chen","year":"2022","unstructured":"Chen, Y., Zhang, Y. G. & Yi, J. Evaluation of postoperative residual curarisation after administration of neostigmine or sugammadex by diaphragmatic ultrasonography: A randomized double-blind controlled trial. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 44(3), 415\u2013421 (2022).","journal-title":"Zhongguo Yi Xue Ke Xue Yuan Xue Bao"},{"key":"18917_CR38","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.redar.2015.01.011","volume":"62","author":"FB De la Quintana-Gordon","year":"2015","unstructured":"De la Quintana-Gordon, F. B., Nacarino-Alcorta, B. & Fajardo-P\u00e9rez, M. Basic lung ultrasound. Part 2. Parenchymal diseases. Rev. Esp. Anestesiol. Reanim. 62, 337\u2013349 (2015).","journal-title":"Rev. Esp. Anestesiol. Reanim."},{"issue":"1","key":"18917_CR39","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1186\/s12871-021-01518-z","volume":"21","author":"MJ Colomina","year":"2021","unstructured":"Colomina, M. J. et al. Observational study on fluid therapy management in surgical adult patients. BMC Anesthesiol. 21(1), 316 (2021).","journal-title":"BMC Anesthesiol."},{"key":"18917_CR40","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S2213-2600(18)30024-9","volume":"6","author":"C Ferrando","year":"2018","unstructured":"Ferrando, C. et al. Individualised perioperative open-lung approach versus standard protective ventilation in abdominal surgery (iPROVE): A randomised controlled trial. Lancet Respir. Med. 6, 193\u2013203 (2018).","journal-title":"Lancet Respir. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-18917-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-18917-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-18917-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T06:18:53Z","timestamp":1662099533000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-18917-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,2]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["18917"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-18917-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,2]]},"assertion":[{"value":"14 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14955"}}